BioSpecifics Technologies Corp. Hits New 52-Week High at $23.86 (BSTC)
Shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) hit a new 52-week high on Wednesday, AR Network reports. The company traded as high as $23.86 and last traded at $23.63, with a volume of 12,207 shares trading hands. The stock had previously closed at $22.87.
A number of research firms have recently commented on BSTC. Analysts at MKM Partners raised their price target on shares of BioSpecifics Technologies Corp. from $24.50 to $28.00 in a research note to investors on Thursday, January 9th. They now have a “buy” rating on the stock.
BioSpecifics Technologies Corp. has a 52 week low of $14.57 and a 52 week high of $23.86. The stock’s 50-day moving average is $21.91 and its 200-day moving average is $19.32. The company has a market cap of $146.5 million and a price-to-earnings ratio of 34.13.
BioSpecifics Technologies Corp. (NASDAQ:BSTC) last announced its earnings results on Tuesday, November 12th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.13. On average, analysts predict that BioSpecifics Technologies Corp. will post $0.69 earnings per share for the current fiscal year.
BioSpecifics Technologies Corp. (NASDAQ:BSTC) is a biopharmaceutical company involved in the development of an injectable collagenase for multiple indications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.